In those over 65, heart failure is the most common reason for hospitalization. Clarification of the cause of the disease is essential to direct patients to targeted therapy. Patients with cardiac ATTR amyloidosis are an important HFpEF subgroup for whom there is a specific therapeutic option that has been shown to improve prognosis.
This content is machine-translated. Please contact us if you need professional translation services.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Cardiac arrhythmias
Atrial fibrillation – what do current guidelines say?
- PANCREATIC CELLS
Exploration map
- DIABETES AND OBESITY
Influence of movement and muscle regulation
- New studies on COPD
From inhalers, allergies and physical activity
- Rare diseases
The Alagille syndrome
- The future is near or here?
Ablation for atrial fibrillation
- Interventional valve therapy
Gender differences
- Anemia